DUALITY ADVISERS, LP - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 316 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.

Quarter-by-quarter ownership
DUALITY ADVISERS, LP ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,543,471
+178.2%
40,405
+162.6%
0.19%
+167.1%
Q2 2023$554,901
-79.0%
15,384
-77.8%
0.07%
-76.7%
Q1 2023$2,646,300
+24.1%
69,293
+84.9%
0.30%
+23.5%
Q4 2022$2,132,953
+341.6%
37,486
+209.5%
0.24%
+367.3%
Q1 2022$483,000
-86.9%
12,113
-86.6%
0.05%
-81.6%
Q3 2021$3,690,000
+344.6%
90,705
+355.6%
0.28%
+293.1%
Q1 2021$830,000
-22.0%
19,907
-50.8%
0.07%
+5.9%
Q3 2020$1,064,000
+20.0%
40,490
+22.4%
0.07%
-16.0%
Q2 2020$887,000
+124.0%
33,078
+48.1%
0.08%
+237.5%
Q4 2019$396,00022,3350.02%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Third Security, LLC 7,048,282$126,799,00027.23%
First Light Asset Management, LLC 1,630,591$29,334,0005.01%
SNYDER CAPITAL MANAGEMENT L P 3,393,057$61,041,0003.48%
Bellevue Group AG 7,663,956$137,874,0002.67%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 307,633$5,531,0002.52%
Lombard Odier Asset Management (Switzerland) SA 900,000$16,191,0002.17%
Elk Creek Partners, LLC 654,362$11,772,0002.02%
DOHENY ASSET MANAGEMENT /CA 127,110$2,254,0001.79%
Granite Investment Partners, LLC 1,277,438$22,981,0001.49%
Amia Capital LLP 69,409$1,249,0001.11%
View complete list of HALOZYME THERAPEUTICS INC shareholders